STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive: We particularly aimed to determine whether the modulation of p38/ERK/STAT5/CREB signaling pathways by ART can play a critical role in mediating its antitumor effects in human CML cells and xenograft mouse model.